Efficacy of oral amphotericin B in AIDS patients with thrush clinically resistant to fluconazole

J Med Vet Mycol. 1994;32(5):389-93. doi: 10.1080/02681219480000511.

Abstract

Reports of thrush clinically refractory to azoles in AIDS patients are increasing with the more widespread use of these agents. We studied our own oral preparation of amphotericin B in the treatment of two AIDS patients who developed oral thrush due to Candida glabrata after prolonged fluconazole use. Improvement occurred in both in less than 1 week, with eventual clearing and absence of side effects. Oral amphotericin B may have advantages over alternatives for this increasing problem.

Publication types

  • Case Reports

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications*
  • Administration, Oral
  • Adult
  • Amphotericin B / administration & dosage*
  • Candidiasis, Oral / complications
  • Candidiasis, Oral / drug therapy*
  • Cost-Benefit Analysis
  • Drug Resistance, Microbial
  • Fluconazole / therapeutic use*
  • Humans
  • Male
  • Treatment Outcome

Substances

  • Amphotericin B
  • Fluconazole